Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Statement of the Austrian Society of Pneumology expert group for interstitial lung diseases and orphan diseases on the 2025 update of the international multidisciplinary classification of interstitial pneumonias].

Wiener klinische Wochenschrift·2026

Same author

Characteristics and Outcomes of Adolescents (15-18 Years) with Chronic Myelogenous Leukemia (CML) in Chronic Phase: The Experience of the International Registry of Childhood CML.

Cancers·2026

Same author

Bone-modifying therapy in multiple myeloma: a comprehensive review.

Frontiers in oncology·2026

Same author

Prognostic impact of spread through air spaces (STAS) in mucin-producing lung adenocarcinoma: a multinational cohort study.

Cancer treatment and research communications·2026

Same author

Removal of pulp tissue remnants from the isthmus area of lower molars using Shock Wave Enhanced Emission Photo-acoustic Streaming and sonic-activated irrigation.

Photodiagnosis and photodynamic therapy·2026

Same author

Update on Pleural Epithelioid Mesothelioma: New Insights for Diagnosis and Patient Management.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Mast-cell sarcoma of the tibia.

Luka Brcić¹, Lovorka Batelja Vuletić, Jasminka Stepan

¹Institute of Pathology, Medical School, University of Zagreb, Zagreb, Croatia.

Journal of Clinical Pathology

|April 5, 2007

Summary

This report details the first case of mast-cell sarcoma of the bone in a child. The aggressive bone tumor rapidly progressed to mast-cell leukemia, proving fatal despite chemotherapy.

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Related Experiment Videos

Last Updated: Jul 15, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Area of Science:

Oncology
Hematology
Pathology

Background:

Mast-cell sarcoma is a rare and aggressive malignant neoplasm.
Bone involvement by mast cell tumors is exceptionally uncommon.

Observation:

A 4-year-old boy presented with a destructive tumor in his right lower leg, causing pain, swelling, and deformity.
Radiological imaging confirmed a destructive bone mass.

Findings:

Histopathology revealed a tumor composed of atypical mast cells with specific cytochemical and immunohistochemical markers (positive for chloroacetate esterase, c-kit, tryptase; negative for myeloperoxidase).
The tumor exhibited features distinct from other bone sarcomas and mast cell disorders.

Implications:

This case highlights a novel presentation of mast cell neoplasia involving bone.
The rapid progression to mast-cell leukemia underscores the aggressive nature of this rare bone sarcoma.
Further research into the pathogenesis and treatment of mast-cell sarcoma of bone is warranted.